-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Maintains Buy on Guardant Health, Raises Price Target to $210

Benzinga·10/27/2026 16:47:52
Listen to the news
BTIG analyst Mark Massaro maintains Guardant Health (NASDAQ:GH) with a Buy and raises the price target from $195 to $210.